Investors who take an interest in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) should definitely note that the Chief Financial Officer, Jason Haas, recently paid US$1.61 per share to buy US$161k worth of...
Source LinkInvestors who take an interest in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) should definitely note that the Chief Financial Officer, Jason Haas, recently paid US$1.61 per share to buy US$161k worth of...
Source Link
Comments